FEATURED SPEAKER: EEG-guided rTMS in Autism Spectrum Disorder --An Open Label Study
Nineteen subjects with ASD were treated with rTMS. Treatment was provided daily, ½ hour a day, 5 days a week for 5 weeks. Results showed that 42% of subjects responded. Corresponding to the clinical improvement, most responders demonstrated significant improvement in EEG alpha synchronization. The present study supports the hypothesis that the ASD syndrome is a clinical manifestation of the brain deficit of anxiety, which should be the primary focus of treatment.
Yi Jin, MD
Dr. Jin has been engaged in neuroscience research at the University of California Irvine for 25 years. One of his studies involves the brain physiology and treatment of autism. In addition to his academic work, Dr. Jin has cofounded two companies, NeoSync, Inc. and Newport Brain Research Laboratory. Neosync manufactures portable neural stimulation equipment. Brain Lab is a psychiatric clinic using EEG and TMS to assist clinical diagnosis and treatment for ASD and other mental disorders.
